What is haemophilia?
Haemophilia is a lifelong, X-linked genetic bleeding disorder which affects around 1 in 10,000 people. People with haemophilia do not have enough of the blood clotting protein (factor) which controls bleeding. This causes them to bleed for a longer time than those whose factor levels are normal. With haemophilia, bleeding often occurs into the muscles or joints. When bleeding occurs frequently into the same joint, the joint can become damaged.
Haemophilia A is the most common form of haemophilia and occurs when the person does not have enough clotting factor VIII (factor eight).
Early on-demand or preventative (prophylactic) therapy to replace the missing coagulation factor is usually able to effectively control or prevent acute bleeding.
Octapharma is a company dedicated to the development of human proteins and continues to be part of this journey of haemophilia care.
Explore the history yourself by scrolling through the years.